Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prevalence of unnecessary kidney function exclusion criteria in urologic oncology clinical trials

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.08.017Source: DataRank Database

Prevalence of unnecessary kidney function exclusion criteria in urologic oncology clinical trials is a research paper published in Urologic Oncology Seminars and Original Investigations (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: closedTopics (36)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Madison Krischak ORCID,Ted A. Skolarus ORCID,Patrick Lewicki ORCID,Rishi Sekar ORCID,Lindsey A. Herrel ORCID

Live enrichment

PubMed:39393993 OpenAlex:https://openalex.org/W4403286194

National Cancer Institute

Grant: F32-CA264874

National Cancer Institute

Grant: K12-DK111011

National Cancer Institute

Grant: P30-CA-046592

National Institutes of Health

FWCI

0.00

Citation Percentile

0.3%

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S1078143924006367?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1078143924006367?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.urolonc.2024.08.017

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39393993

Fields of Study

Renal cell carcinoma treatmentChronic Kidney Disease and DiabetesAcute Kidney Injury ResearchHumansClinical Trials, Phase III as TopicKidneyKidney Function TestsMedical OncologyPatient SelectionPrevalenceUrologic Neoplasms

MeSH Terms

Clinical Trials as TopicHumansKidneyKidney Function TestsMedical OncologyUrologic NeoplasmsPrevalenceClinical Trials, Phase III as TopicPatient Selection

Keywords

MedicineClinical trialLimitingKidney cancerRenal functionIntensive care medicinePsychological interventionClinical OncologyOncologyInternal medicineCancerFamily medicineNursingClinical TrialsKidney FunctionEligibility Criteria

Sustainable Development Goals

SDG 0: Reduced inequalities